Bowel cancer “melted away” after immunotherapy, then stayed away
A short course of immunotherapy before surgery may offer remarkably durable protection for some patients with stage two or three bowel cancer. In the NEOPRISM-CRC trial, 32 patients with a specific genetic form of bowel cancer received…
Read the full story at ScienceDaily Health ↗
ImpactMinor 28/100
Why it mattersRule-based estimate: no strong signals; trust 6/10.
RegionsGlobal
Published3 h ago (Sat, 10 Oct 2026 18:42:35 GMT)
RetrievedSat, 10 Oct 2026 21:00:15 GMT via rss
ClassifiedSat, 10 Oct 2026 21:00:27 GMT by heuristic